36 related articles for article (PubMed ID: 11789762)
1. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
[TBL] [Abstract][Full Text] [Related]
2. HER3 expression and MEK activation in non-small-cell lung carcinoma.
Manickavasagar T; Yuan W; Carreira S; Gurel B; Miranda S; Ferreira A; Crespo M; Riisnaes R; Baker C; O'Brien M; Bhosle J; Popat S; Banerji U; Lopez J; de Bono J; Minchom A
Lung Cancer Manag; 2021 Apr; 10(2):LMT48. PubMed ID: 34084213
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway.
Wang F; Chen J; Xiang D; Lian X; Wu C; Quan J
Am J Transl Res; 2020; 12(5):2295-2304. PubMed ID: 32509220
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations.
Sandfeld-Paulsen B; Folkersen BH; Rasmussen TR; Meldgaard P; Sorensen BS
Transl Oncol; 2016 Aug; 9(4):306-12. PubMed ID: 27567953
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Yu T; Li J; Yan M; Liu L; Lin H; Zhao F; Sun L; Zhang Y; Cui Y; Zhang F; Li J; He X; Yao M
Oncogene; 2015 Jan; 34(4):413-23. PubMed ID: 24469061
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC).
Bellezza G; Del Sordo R; Colella R; Ludovini V; Ragusa M; Bianconi F; Ferri I; Borri F; Chiari R; Puma F; Crinò L; Sidoni A
Virchows Arch; 2013 Nov; 463(5):663-71. PubMed ID: 24013863
[TBL] [Abstract][Full Text] [Related]
7. The promise of anti-ErbB3 monoclonals as new cancer therapeutics.
Aurisicchio L; Marra E; Roscilli G; Mancini R; Ciliberto G
Oncotarget; 2012 Aug; 3(8):744-58. PubMed ID: 22889873
[TBL] [Abstract][Full Text] [Related]
8. EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study.
Sousa V; Espírito Santo J; Silva M; Cabral T; Alarcão AM; Gomes A; Couceiro P; Carvalho L
Virchows Arch; 2011 May; 458(5):571-81. PubMed ID: 21424799
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal and genomic changes in lung cancer.
Varella-Garcia M
Cell Adh Migr; 2010; 4(1):100-6. PubMed ID: 20139701
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.
Kim SJ; Rabbani ZN; Dong F; Vollmer RT; Schreiber EG; Dewhirst MW; Vujaskovic Z; Kelley MJ
Med Oncol; 2010 Mar; 27(1):91-7. PubMed ID: 19235531
[TBL] [Abstract][Full Text] [Related]
11. The ERBB3 receptor in cancer and cancer gene therapy.
Sithanandam G; Anderson LM
Cancer Gene Ther; 2008 Jul; 15(7):413-48. PubMed ID: 18404164
[TBL] [Abstract][Full Text] [Related]
12. Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
Sithanandam G; Smith GT; Fields JR; Fornwald LW; Anderson LM
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):490-9. PubMed ID: 16055672
[TBL] [Abstract][Full Text] [Related]
13. Expression of the epidermal growth factor system in endometrial cancer.
Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
15. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
[TBL] [Abstract][Full Text] [Related]
16. [New development lines in immunology. Perspective of pathology].
Rüschoff J; Zielinski D; Heinmöller E
Pathologe; 2013 Nov; 34 Suppl 2():226-9. PubMed ID: 24196618
[No Abstract] [Full Text] [Related]
17. Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach.
Gandara DR; Lara PN; Lau DH; Mack P; Gumerlock PH
Lung Cancer; 2001 Dec; 34 Suppl 3():S75-80. PubMed ID: 11740998
[No Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer.
Lai WW; Chen FF; Wu MH; Chow NH; Su WC; Ma MC; Su PF; Chen H; Lin MY; Tseng YL
Ann Thorac Surg; 2001 Dec; 72(6):1868-76. PubMed ID: 11789762
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
